Clinical and molecular effects on mature burn scars after treatment with a fractional CO2 laser

Lasers in Surgery and Medicine

Volumn 44, Issue 7, 2012, Pages 517-524

  Qu, Le ^a,b,c   Liu, Austin ^b   Zhou, Li ^a,b   He, Chundi ^c   Grossman, Peter H ^d   Moy, Ronald L ^e   Mi, Qing Sheng ^a,b   Ozog, David ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c CHINA MEDICAL UNIVERSITY   (China)

^d Grossman Burn Center   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bFGF; fractional CO2 laser; microRNAs; miR 17 92; MMP 1; scar; TGF

Indexed keywords

COLLAGENASE 3; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN TYPE 1; PROCOLLAGEN TYPE 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BURN SCAR; CARBON DIOXIDE LASER; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE CLUSTER; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TREATMENT RESPONSE; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; BURNS; CICATRIX, HYPERTROPHIC; DOWN-REGULATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LASERS, GAS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; UP-REGULATION;

EID: 84865358384     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22055     Document Type: Article

References (31)

1. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB,. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993; 55 (2): 214-222. (Pubitemid 23335800)
2. Naouri M, Atlan M, Perrodeau E, Georgesco G, Khallouf R, Martin L, Machet L,. High-resolution ultrasound imaging to demonstrate and predict efficacy of carbon dioxide fractional resurfacing laser treatment. Dermatol Surg 2011; 37 (5): 596-603.
3. Ozog DM,. Predicting efficacy of fractional carbon dioxide laser treatment for resurfacing. Dermatol Surg 2011; 37 (5): 604.
4. Waibel J, Beer K,. Fractional laser resurfacing for thermal burns. J Drugs Dermatol 2008; 7 (1): 59-61.
5. Waibel J, Beer K,. Ablative fractional laser resurfacing for the treatment of a third-degree burn. J Drugs Dermatol 2009; 8 (3): 294-297.
6. Ulrich D, Ulrich F, Unglaub F, Piatkowski A, Pallua N,. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. J Plast Reconstr Aesthet Surg 2010; 63 (6): 1015-1021.
7. Fujiwara M, Muragaki Y, Ooshima A,. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005; 153 (2): 295-300. (Pubitemid 41228425)
8. Douglas HE,. TGF-ßs in wound healing: A review. J Wound Care 2010; 19 (9): 403-406.
9. Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U,. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol 2005; 85 (3): 216-220. (Pubitemid 40695163)
10. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT,. Expression of transforming growth factor beta 1, 2 and 3 proteins in keloids. Ann Plast Surg 1999; 43 (2): 179-184. (Pubitemid 29380019)
11. Huang J, Luo X, Lu J, Chen J, Zuo C, Xiang Y, Yang S, Tan L, Kang J, Bi Z,. IPL irradiation rejuvenates skin collagen via the bidirectional regulation of MMP-1 and TGF-beta1 mediated by MAPKs in fibroblasts. Lasers Med Sci 2011; 26 (3): 381-387.
12. Viera MH, Amini S, Valins W, Berman B,. Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol 2010; 3 (5): 20-26.
13. Cheng J, Yu H, Deng S, Shen G,. MicroRNA profiling in mid- and late-gestational fetal skin: Implication for scarless wound healing. Tohoku J Exp Med 2010; 221 (3): 203-209.
14. Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K, Utani A, Hirano A, Yamashita S,. miR-196a downregulation increases the expression of Type I and III collagens in keloid fibroblasts. J Invest Dermatol 2012; 132 (6): 1597-1604.
15. Liu Y, Yang D, Xiao Z, Zhang M,. miRNA Expression profiles in keloid tissue and corresponding normal skin tissue. Aesthetic Plast Surg 2012; 36 (1): 193-201.
16. Sand M, Gambichler T, Sand D, Skrygan M, Altmeyer P, Bechara FG,. MicroRNAs and the skin: Tiny players in the body's largest organ. J Dermatol Sci 2009; 53 (3): 169-175.
17. Sullivan T, Smith J, Kermode J, McIver E, Courtemanche DJ,. Rating the burn scar. J Burn Care Rehabil 1990; 11 (3): 256-260.
18. Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP,. The patient and observer scar assessment scale: A reliable and feasible tool for scar evaluation. Plast Reconstr Surg 2004; 113 (7): 1960-1965; discussion 1966-1967. (Pubitemid 39201711)
19. Ala-Kokko L, Rintala A, Savolainen ER,. Collagen gene expression in keloids: Analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987; 89 (3): 238-244. (Pubitemid 17126576)
20. Kuo YR, Wu WS, Jeng SF, Wang FS, Huang HC, Lin CZ, Yang KD,. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005; 36 (1): 38-42. (Pubitemid 40224029)
21. Lanning DA, Diegelmann RF, Yager DR, Wallace ML, Bagwell CE, Haynes JH,. Myofibroblast induction with transforming growth factor-beta1 and -beta3 in cutaneous fetal excisional wounds. J Pediatr Surg 2000; 35 (2): 183-187; discussion 187-188.
22. Shah M, Foreman DM, Ferguson MW,. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108 (Pt 3): 985-1002.
23. Kuo YR, Jeng SF, Wang FS, Chen TH, Huang HC, Chang PR, Yang KD,. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression. Lasers Surg Med 2004; 34 (2): 104-108. (Pubitemid 38326352)
24. Dews M, Fox JL, Hultine S, Sundaram P, Wang W, Liu YY, Furth E, Enders GH, El-Deiry W, Schelter JM, Cleary MA, Thomas-Tikhonenko A,. The myc-miR-17â92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res; 2010; 70 (20): 8233-8246.
25. Olive V, Jiang I,. He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 2010; 42 (8): 1348-1354.
26. Grillari J, Hackl M, Grillari-Voglauer R,. miR-17-92 cluster: Ups and downs in cancer and aging. Biogerontology 2010; 11 (4): 501-506.
27. Li H, Chen J, Chen S, Zhang Q,. Antifibrotic effects of Smad4 small interfering RNAs in injured skeletal muscle after acute contusion. Int J Sports Med 2011; 32 (10): 735-742.
28. Tan WQ, Gao ZJ, Xu JH, Yao HP,. Inhibiting scar formation in vitro and in vivo by adenovirus-mediated mutant Smad4: A preliminary report. Exp Dermatol 2011; 20 (2): 119-124.
29. Amjad SB, Carachi R, Edward M,. Keratinocyte regulation of TGF-beta and connective tissue growth factor expression: A role in suppression of scar tissue formation. Wound Repair Regen 2007; 15 (5): 748-755. (Pubitemid 47493893)
30. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Grotendorst GR, Takehara K,. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996; 106 (4): 729-733. (Pubitemid 26119731)
31. Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, Roy NK, Dean NM, Mustoe TA,. Antisense inhibition of connective tissue growth factor (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen 2008; 16 (5): 661-673.